- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
A pharmacist complained a launch letter promoted off-label use of Melatonin 1mg/ml Oral Solution. The Panel ruled the…
Roche challenged two GSK corporate press releases about lapatinib (Tykerb/Tyverb). The Panel found one release misleading on adverse…
Merz promoted Xeomin as “At least as effective as Botox with a similar safety profile” on an exhibition…
Anonymous alleged an AstraZeneca meeting misled attendees and promoted Seroquel for borderline personality disorder. Panel found no evidence…
Two near-identical MSD Connect emails with different subject lines were sent within seconds due to a third-party technical…
Takeda challenged AstraZeneca’s “No other LHRHa has demonstrated survival benefits in all 3 stages…” claim in a Zoladex…
PMCPA case AUTH/3075/9/18 (Director v Lundbeck) concerned clinical trial disclosure but was ruled outwith the scope of the…
A hospital pharmacist alleged ProStrakan reps discussed Abstral for post-operative urology patients (off-label). Panel found the complaint not…
A renal nurse complained that Durogesic DTrans branded pens were in BRS 2013 delegate bags. Panel found a…
MIMS “abbreviated” CosmoCol ad included pack size/cost and other claims, so needed prescribing info. Both the ad and…
One real case. One key lesson. Every week — free.